U.S. Aerospace & Defense Stock News

Digi International recently launched the Digi IX25, a rugged industrial cellular router platform offering integrated Gigabit Ethernet, Western cellular modules, private LTE/5G support, and centralized management via Digi Remote Manager, and it is now available through the company’s global sales and channel partners. A key angle for investors is how Digi IX25 combines edge computing, Linux containers, and AI-enabled fleet management to let industrial and government customers consolidate...

On March 25, 2026, Colgate-Palmolive disclosed that it had received two shareholder proposals, one seeking an independent board chair and another aiming to remove DEI-related criteria from board candidate selection, both of which the company urged shareholders to vote against at its May 8, 2026 annual meeting. These governance-focused proposals highlight an intensifying debate over how Colgate-Palmolive structures board oversight and approaches diversity considerations at the highest...

Why Cintas’ updated outlook is back in focus Cintas (CTAS) is back on investor radars after raising earnings guidance for fiscal 2026 and outlining expected annual revenue of about US$11.21b to US$11.24b, along with fresh third quarter and nine month results. See our latest analysis for Cintas. Despite the raised earnings outlook and stronger recent quarterly figures, Cintas’ 1 month share price return of a 16.37% decline and year to date share price return of a 7.90% decline point to fading...

Southwest Airlines recently began service at Santa Rosa’s Charles M. Schulz Sonoma County Airport, adding nonstop flights to San Diego, Las Vegas, Denver, and Burbank, while also continuing broader network expansion to destinations such as St. Thomas, St. Maarten, Knoxville, and Anchorage. The carrier also introduced its Sip and Ship program, letting customers check one case of wine for free from select West Coast airports, underscoring a focus on differentiated perks amid rising fuel costs...

Freedom Telecom International, a subsidiary of Freedom Holding Corp., previously entered into an agreement with global technology group e& to create a structured framework for pursuing worldwide telecom and digital ecosystem opportunities while maintaining full operational independence. This collaboration uniquely blends FTI’s digital transformation and fintech capabilities with e&’s telecom reach, potentially positioning Freedom Holding closer to high-growth, service-based digital revenue...

Bath & Body Works (NYSE:BBWI) is marking the 20th anniversary of its Japanese Cherry Blossom fragrance with new product launches. The celebration includes a complementary fragrance and the return of a nostalgic scent to the lineup. This anniversary campaign is accompanied by a marketing push aimed at highlighting the brand's fragrance heritage. For a retailer focused on personal care, home fragrance, and body care, a fragrance icon like Japanese Cherry Blossom is a key part of the brand...

Iran's Islamic Revolutionary Guard Corps publicly flagged U.S. and Israeli-linked infrastructure as potential targets, specifically naming the planned US$30b Stargate AI data center project in Abu Dhabi, where NYSE:ORCL is a partner. Oracle is also facing a class action securities lawsuit and legal investigation focused on its AI infrastructure disclosures, including questions around the scale of spending and reliance on additional debt. These developments raise fresh geopolitical,...

Agios Pharmaceuticals recently reported that, following a pre-supplemental New Drug Application meeting, the FDA encouraged it to seek U.S. accelerated approval of mitapivat for sickle cell disease and submit a confirmatory trial proposal based on the RISE UP Phase 2 and 3 data package. The move to accelerated approval, with a new confirmatory trial endpoint and operating expenses expected to remain roughly flat versus 2025, could reshape how investors view Agios’s risk–reward profile around...

Boston Scientific (NYSE:BSX) has completed the acquisition of Valencia Technologies. The deal adds the eCoin tibial nerve stimulation device for urinary incontinence to its portfolio. The transaction moves Boston Scientific further into the urinary incontinence market, which remains under penetrated. At a current share price of $61.86, Boston Scientific enters this deal after a period of mixed share performance, with a 21.9% return over 3 years and 57.0% over 5 years, but a 34.7% decline...

On 30 March 2026, Quantum Corridor and Quantum Computing Inc. announced the installation of a QCi Dirac-3 quantum optimization machine at the Digital Crossroad Data Center in Hammond, Indiana, providing secure, on-demand access over Quantum Corridor's high-speed, quantum-enabled fiber network. This first commercial data center deployment of Dirac-3, integrated with Toshiba’s Quantum Key Distribution-secured 10G link, introduces a new subscription-based access model that could broaden...

Insider selling and analyst updates put Privia Health Group (PRVA) in focus Privia Health Group (PRVA) is back on investor radar after Chief Financial Officer David Mountcastle sold 5,566 shares, followed by a fresh round of analyst updates after the company’s Q4 earnings release. See our latest analysis for Privia Health Group. At a share price of $22.38, Privia Health Group has seen short term momentum pick up, with a 1 day share price return of 3.66% and a 7 day share price return of...

Analyst estimate revisions bring Laureate Education (LAUR) into focus Fresh analyst commentary around Laureate Education (LAUR) is centering on higher earnings estimates, with current year EPS forecasts and expected growth now set above the industry average, pulling more investor attention to the stock. See our latest analysis for Laureate Education. At a share price of $34.30, Laureate Education has paired a recent 8.3% 1 month share price return with a very large 5 year total shareholder...

Why Teleflex is Back on Investors’ Radar Teleflex (TFX) has attracted renewed attention after recent share price moves, with the stock up over the past month but lower over the past 3 months and year to date. See our latest analysis for Teleflex. Teleflex’s recent 1 month share price return of 1.94% sits against a weaker backdrop, with a 3 month share price return showing an 8.71% decline and a 1 year total shareholder return reflecting an 8.10% loss, suggesting momentum has been fading...

In recent days, TTM Technologies reported strong annual revenue expansion of 14.1% over the last two years and accelerating demand, with analysts expressing increasingly positive views on the business. This combination of rapid earnings compounding and growing market share across aerospace, defense, and advanced PCB markets has reinforced confidence in TTM’s positioning across mission-critical end markets. Next, we’ll examine how this rapid revenue and earnings growth may reshape TTM...

In late March 2026, General Mills launched two new cereals, Lucky Charms Unicorn Cotton Candy and Tropical Trix featuring Disney’s Moana, made with colors from natural sources and rolling out nationwide this summer. These launches also highlight General Mills’ progress toward removing certified colors from its entire U.S. cereal portfolio by summer 2026 and its full U.S. retail portfolio by the end of 2027. Next, we’ll examine how concerns about rising input costs and margin pressure may...

Cirrus Logic, Inc. recently disclosed that effective March 25, 2026, Chief Financial Officer Jeff Woolard also became Principal Accounting Officer, while former Principal Accounting Officer Ulf Habermann moved into a senior role within the finance team without any disagreement over company operations or policies. At the same time, Cirrus Logic’s stronger-than-expected fiscal third-quarter results and its role in Apple’s expanded American Manufacturing Program highlight both operational...

Celldex Therapeutics (CLDX) recently closed a large underwritten public equity offering, raising about US$345 million soon after sharing new Phase 2 barzolvolimab data in multiple chronic urticaria indications at a major dermatology conference. See our latest analysis for Celldex Therapeutics. At a share price of US$31.35, Celldex has logged a 1 month share price return of 6.52% and a year to date share price return of 16.07%. The 1 year total shareholder return of 107.20% contrasts with a...

Morningstar (MORN) caught fresh attention after expanding the availability of its investment data on Snowflake Marketplace, giving institutional clients broader access to indexes, ESG ratings, credit ratings, and analytics directly within Snowflake environments. See our latest analysis for Morningstar. Despite the Snowflake partnership and recent milestones at Morningstar DBRS, Morningstar’s 7 day share price return of 4.5% sits against a weaker backdrop, with a 30 day share price decline of...

In late March 2026, iRhythm Holdings replaced PricewaterhouseCoopers with KPMG as its independent auditor and unveiled extensive new clinical data, AI initiatives, and product enhancements for its Zio ambulatory ECG monitoring service at the American College of Cardiology 2026 meeting. The company’s use of billions of hours of curated heartbeat data to inform AI-driven arrhythmia risk prediction and clinician education underscores how deeply data and analytics are becoming embedded in its...

Preferred Bank recently reported quarterly results showing revenue up 7.2% year on year, beating analyst estimates by 4.8%, while earnings per share matched expectations. Chairman and CEO Li Yu emphasized that the bank’s profitability sits in the top tier of the banking industry, underscoring the quality of its earnings rather than just their size. We’ll now examine how this revenue outperformance and management’s emphasis on top-tier profitability affect Preferred Bank’s existing investment...

Artificial intelligence in healthcare is one of the clearest ways technology meets real world need, especially as higher energy prices, geopolitical tension, and sticky inflation keep pressure on costs and productivity. While many sectors face softer activity and rising input prices, AI tools that support better diagnostics, smoother hospital operations, and faster drug discovery speak directly to efficiency and outcomes. This screener focuses on companies applying AI to these problems,...

Becton, Dickinson and Company recently launched the HemoSphere Stream Module for continuous, noninvasive blood pressure monitoring and introduced the BD Pyxis Pro Dispensing Solution and BD Incada Connected Care Platform in Europe to modernize medication management and analytics. These launches highlight BD’s push into connected, data-rich hospital workflows, linking bedside monitoring with cloud-based medication insights across a broad installed base. We’ll now examine how BD’s expansion of...

Magnite at a glance Magnite (MGNI) sits at the center of the sell side of digital advertising, connecting publishers and buyers across connected TV, apps, websites, and other media properties through its independent advertising platform. With revenue of US$713.953 million and net income of US$144.613 million, the company generates most of its sales in the United States. International operations add a meaningful secondary revenue stream. See our latest analysis for Magnite. Magnite’s share...

SBA Communications (SBAC) has drawn investor attention after recent share price moves, including a 3.1% one day decline and gains over the past week, month and past 3 months. These shifts highlight its focus as a tower-oriented REIT. See our latest analysis for SBA Communications. The recent 7 day share price return of 19.61% and 90 day share price return of 13.47% contrast with a 3 year total shareholder return of 17.45% and 5 year total shareholder return of 21.38% declines, suggesting...